Management of Menopause
| GEHC-SHSWH-DRSE-HT9191 | |
| Clinical Training | |
| GE HealthCare | |
Add to Wish List
Login To Shop
Please select date
Second Opinion Approval Needed
Enter your approval number and submit to add item(s) to cart.
Approval Number
Please enter approval number
OR
Don't know your approval number? Call 800-437-1171
Enter opt 1 for the first three prompts, and have your System ID available.
If you add item(s) to cart and submit your order without the
approval number, GE will contact you before your order
can be confirmed for shipment.
Second Opinion Approval Needed
Select your approver's name and submit to add item(s) to your cart
Approver Name
Please Select Approver Name
OR
Don't know your approval number? Call 800-437-1171
Enter opt 1 for the first three prompts, and have your System ID available.
If you add item(s) to cart and submit your order without
selecting an approver, GE will contact you before your order
can be confirmed for shipment.
Product Overview
Disease prevalence increases substantially about 10 years after menopause and provides an opportunity to institute prevention strategies at the onset of menopause. The Womenâs Health Initiative was largely misinterpreted and many women have been denied appropriate hormone therapy. Hormone therapy in younger women decreases mortality, a finding consistent with the data from older observational trails. Hormone therapy is efficacious for menopause symptoms and the prevention of osteoporosis. Compelling evidence points to the possibility of considering hormone therapy as part of the strategy for prevention. After completing this course, you should be able to: ⢠Describe the changes that occur after menopause and the long-term consequences. ⢠Identify the current indications for hormone therapy. ⢠Define the findings of the Womenâs Health Initiative studies and their current interpretation. ⢠Describe the true risks and benefits of hormone therapy symptoms and prevention of osteoporosis. ⢠Identify alternatives to the use of hormones for menopausal symptoms and prevention of osteoporosis. ⢠Describe the risk-to-benefit equation in younger women at the onset of menopause (compared to older women) and the possibility of the role of hormone therapy as a prevention therapy.
